BioGaia AB (BIOGY)
11.50
0.00 (0.00%)
USD |
OTCM |
Sep 27, 16:00
BioGaia Total Liabilities (Quarterly): 30.66M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 30.66M |
March 31, 2024 | 29.28M |
December 31, 2023 | 30.08M |
September 30, 2023 | 29.22M |
June 30, 2023 | 25.16M |
March 31, 2023 | 22.90M |
December 31, 2022 | 23.18M |
September 30, 2022 | 28.06M |
June 30, 2022 | 32.89M |
March 31, 2022 | 29.62M |
December 31, 2021 | 27.71M |
September 30, 2021 | 14.66M |
June 30, 2021 | 17.71M |
March 31, 2021 | 17.03M |
December 31, 2020 | 20.40M |
September 30, 2020 | 14.98M |
June 30, 2020 | 16.40M |
March 31, 2020 | 17.02M |
December 31, 2019 | 16.91M |
September 30, 2019 | 18.77M |
June 30, 2019 | 19.42M |
March 31, 2019 | 17.44M |
December 31, 2018 | 16.91M |
September 30, 2018 | 16.54M |
June 30, 2018 | 18.12M |
Date | Value |
---|---|
March 31, 2018 | 14.24M |
December 31, 2017 | 13.72M |
September 30, 2017 | 12.89M |
June 30, 2017 | 12.28M |
March 31, 2017 | 11.84M |
December 31, 2016 | 8.14M |
September 30, 2016 | 9.553M |
June 30, 2016 | 9.306M |
March 31, 2016 | 8.829M |
December 31, 2015 | 9.198M |
September 30, 2015 | 9.326M |
June 30, 2015 | 10.81M |
March 31, 2015 | 10.16M |
December 31, 2014 | 9.161M |
September 30, 2014 | 8.762M |
June 30, 2014 | 12.62M |
March 31, 2014 | 11.33M |
December 31, 2013 | 10.38M |
September 30, 2013 | 9.891M |
June 30, 2013 | 9.448M |
March 31, 2013 | 9.778M |
December 31, 2012 | 9.264M |
September 30, 2012 | 12.92M |
June 30, 2012 | 16.28M |
March 31, 2012 | 19.35M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
14.66M
Minimum
Sep 2021
32.89M
Maximum
Jun 2022
23.13M
Average
23.04M
Median
Total Liabilities (Quarterly) Benchmarks
Abliva AB | 0.7797M |
Karolinska Development AB | 1.264M |
Calliditas Therapeutics AB | 154.56M |
Oncopeptides AB | 14.80M |
BioInvent International AB | 9.562M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 179.09M |
Shareholders Equity (Quarterly) | 148.43M |
Current Ratio | 6.489 |